Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.03. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy at the AACR 2024 Annual Meeting | 295 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / March 19, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs... ► Artikel lesen | |
11.03. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Early Safety Data from the Company's Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy Met the Study's Initial Pre-Specified Objective | 248 | ACCESSWIRE | Safety in the Phase 1b part of Sonnet's double-blind, randomized, controlled trial of SON-080 was reviewed by the study's Data Safety Monitoring Board (DSMB)The adverse event profile and tolerability... ► Artikel lesen | |
06.03. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
29.02. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers | 359 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / February 29, 2024 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today... ► Artikel lesen | |
14.02. | Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary | 2 | Reuters | ||
14.02. | Sonnet BioTherapeutics GAAP EPS of -$0.31, revenue of $18.63M | 1 | Seeking Alpha | ||
14.02. | Sonnet BioTherapeutics GAAP EPS of -$0.31 | 1 | Seeking Alpha | ||
14.02. | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update | 321 | ACCESSWIRE | Successfully raised approximately $4.55 million in gross proceeds through an underwritten public offeringExtensive preclinical data on SON-1210 published in Frontiers in ImmunologyReceived approval... ► Artikel lesen | |
14.02. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.02. | Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
13.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.02.2024 - 4 | 4.355 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 13.02.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.02.2024ISIN NameUS42328V8019 HELIUS... ► Artikel lesen | |
29.01. | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
27.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
22.12.23 | Sonnet BioTherapeutics files for $100M mixed shelf | 6 | Seeking Alpha | ||
21.12.23 | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy | 295 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / December 21, 2023 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for cancer, announced today... ► Artikel lesen | |
15.12.23 | Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in September - Earnings Summary | 4 | Reuters | ||
14.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
14.12.23 | Sonnet BioTherapeutics Holdings, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
14.12.23 | Sonnet BioTherapeutics GAAP EPS of -$18.14 beats by $9.99, revenue of $0.15M in-line | 3 | Seeking Alpha | ||
14.12.23 | Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update | 622 | ACCESSWIRE | PRINCETON, NJ / ACCESSWIRE / December 14, 2023 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
KRAFT HEINZ | 35,645 | -0,32 % | Kraft Natural Cheese releases line of flavor fusions: Follows the launch of Kraft Signature Shreds in March | ||
BEYOND MEAT | 6,090 | +2,98 % | Goldman looks to tap private credit markets for Beyond Meat cash | ||
MODERN PLANT BASED FOODS | 0,037 | -13,08 % | Modern Plant-Based Foods meldet Erstinteresse des weltweit meistbesuchten Themenparks und Unterhaltungskonglomerats | VANCOUVER, BC, 26. Januar 2024 / IRW-Press / Modern Plant Based Foods Inc., (CSE: MEAT) ("Modern Foods") oder (das "Unternehmen"), ein führender Anbieter in der pflanzlichen
Lebensmittelindustrie... ► Artikel lesen | |
LUCKIN COFFEE | 19,400 | 0,00 % | Luckin Coffee Inc. Announces Fourth Quarter and Full Year 2023 Financial Results | Fiscal Year 2023 Net Revenues Increased 87% More than 8,000 Net New Store Openings in Fiscal Year 2023; Ended 2023 with More than 16,200 Stores in China BEIJING, Feb. 23, 2024 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
YUM! BRANDS | 131,70 | -0,15 % | Deshalb sind Yum! Brands und McDonald's Champions für den Vermögensaufbau | Guten Tag, liebe Leserinnen und Leser,
die Restaurants kennen alle, das Unternehmen dahinter vermutlich weit weniger Menschen: Yum! Brands betreibt seit Jahrzehnten erfolgreiche Restaurantketten wie... ► Artikel lesen | |
KROGER | 52,37 | +0,50 % | Kroger Agrees With C&S For Updated Divestiture Package To Address Concerns Raised By Regulators | WASHINGTON (dpa-AFX) - The Kroger Co. (KR) and Albertsons Companies (ACI) have amended their definitive agreement with C&S Wholesale Grocers, LLC for the sale of assets in connection with their... ► Artikel lesen | |
OATLY GROUP | 0,816 | +0,49 % | Oatly Aktie: Kurssturz trotz Trendwende? | Mit einem aktuellen Kurs von 0,98 € und einem Rückgang von 1,8% in der vergangenen Woche steht Oatly, das Unternehmen für vegane Lebensmittel, vor einer Herausforderung. Der allgemeine Abkühlung des... ► Artikel lesen | |
CHIPOTLE MEXICAN GRILL | 2.900,00 | -0,09 % | Aktie von Chipotle Mexican Grill im Höhenflug: Papier legt um 5,19 Prozent zu (2.868,69 €) | Im US-amerikanischen Wertpapierhandel brilliert aktuell der Anteilsschein von Chipotle Mexican Grill . Der Titel verteuert sich heute deutlich. Ein Preisanstieg auf zwischenzeitlich 3.078,54 US-Dollar... ► Artikel lesen | |
VILLAGE FARMS | 1,206 | +1,52 % | Village Farms International, Inc. - 8-K, Current Report | ||
BLENDER BITES | 0,920 | -17,86 % | Blender Bites Limited: Blender Bites Expands U.S. Retail Presence with Launch into Southeastern Grocers Inc. | VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Blender Bites Limited (the "Company", "Blender Bites" or "Blender"), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), a multi award-winning Canadian... ► Artikel lesen | |
DOMINOS PIZZA INC | 461,65 | +0,09 % | Domino's (DPZ) Gears Up for Q1 Earnings: What's in Store? | ||
CAVA GROUP | 62,54 | 0,00 % | Kurzarbeit beim Cava-Hersteller Freixenet wegen Dürre in Katalonien | WIESBADEN/SANT SADURNÍ D'ANOIA (dpa-AFX) - Der Schaumweinhersteller Freixenet hat wegen der Folgen der wohl gravierendsten Dürre in Katalonien seit Beginn der Wetteraufzeichnungen mit verdorrenden... ► Artikel lesen | |
FIRST WATCH RESTAURANT GROUP | 23,630 | 0,00 % | First Watch Restaurant Group, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024 | ||
KURA SUSHI USA | 109,31 | 0,00 % | Kura Sushi opens global flagship in Ginza | ||
MAMAS CREATIONS | 5,540 | 0,00 % | TAL Education and Mama's Creations among Consumer Staples movers |